TrialZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2015
[Imatinib mesylate for chronic myeloid leukemia: in patients with initial treatment versus those with Recombinant Human IFN-α2b treatment failure].
Jin-hong Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.